| Net income | |
| Depreciation and amortization | 5.9M |
| Benefit from deferred income taxes | 0 |
| Provision for returns and doubtful accounts | |
| Compensation expense related to equity compensation plans | 1.4M |
| Return of common stock | |
| Excess tax benefit from exercises of stock options | |
| Loss on dispositions and abandonment | -400K |
| Accounts receivable | 34.2M |
| Inventories | 25.2M |
| Prepaid expenses and other current assets | 4.8M |
| Accounts payable, accrued expenses and other current liabilities | |
| Net cash provided by (used in) operating activities | -58.1M |
| Purchases of property, plant and equipment | -2.9M |
| Proceeds from disposals of property, plant and equipment | 600K |
| Net cash used in investing activities | -2.3M |
| Borrowings on credit facility and short term debt | |
| Repayments of borrowings on credit facility and short term debt | |
| Proceeds from Long-term Capital Lease Obligations | |
| Repayments from capital lease obligations | -300K |
| Proceeds from issuance of common stock | |
| Excess tax benefit from exercises of stock options | |
| Net cash provided by financing activities | -2.2M |
| Effects of exchange rates on cash | -100K |
| Net increase (decrease) in cash | -62.7M |
| Cash - beginning of period | 215.1M |
| Cash - end of period | 152.4M |
| Acquisitions of equipment through capital leases | |